FDA inspection
Wuhan Chinese Moxibustion Technology Dev. Co., Ltd.: FDA inspection ending May 26, 2017
FDA inspection 1016658 · Official Action Indicated (OAI) · Wuhan
Key facts
| Inspection ID | 1016658 |
|---|---|
| Firm | Wuhan Chinese Moxibustion Technology Dev. Co., Ltd. |
| FEI number | 3004859058 |
| Address | Miaoshan Pharmaceutical Industry Park, East Lake High-Tech Dev. Zone |
| City | Wuhan |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | May 26, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 537648 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data